IACCARINO, ANTONINO
 Distribuzione geografica
Continente #
AS - Asia 3.172
NA - Nord America 2.748
EU - Europa 2.503
SA - Sud America 340
AF - Africa 75
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.842
Nazione #
US - Stati Uniti d'America 2.660
SG - Singapore 1.405
RU - Federazione Russa 1.125
IT - Italia 646
VN - Vietnam 590
CN - Cina 574
BR - Brasile 276
HK - Hong Kong 233
DE - Germania 176
FR - Francia 94
IN - India 93
NL - Olanda 91
GB - Regno Unito 84
FI - Finlandia 71
JP - Giappone 51
CA - Canada 41
KR - Corea 36
ES - Italia 33
BD - Bangladesh 32
SE - Svezia 32
IE - Irlanda 31
MX - Messico 28
AR - Argentina 27
ZA - Sudafrica 25
UA - Ucraina 24
PL - Polonia 22
CI - Costa d'Avorio 20
TH - Thailandia 20
IQ - Iraq 19
GR - Grecia 17
PH - Filippine 15
EC - Ecuador 14
PK - Pakistan 14
TR - Turchia 14
ID - Indonesia 13
LT - Lituania 12
AT - Austria 9
JO - Giordania 9
UZ - Uzbekistan 9
TW - Taiwan 8
RS - Serbia 6
BE - Belgio 5
CO - Colombia 5
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
KE - Kenya 5
SA - Arabia Saudita 5
VE - Venezuela 5
CH - Svizzera 4
PE - Perù 4
RO - Romania 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
MA - Marocco 3
NP - Nepal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CL - Cile 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
KW - Kuwait 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
GF - Guiana Francese 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IR - Iran 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
Totale 8.834
Città #
Singapore 703
San Jose 560
Ashburn 280
Moscow 251
Chandler 238
Hong Kong 226
Beijing 191
Ho Chi Minh City 173
Naples 164
Hanoi 126
Hefei 120
Santa Clara 87
Los Angeles 82
The Dalles 77
Lauterbourg 65
Millbury 64
Munich 59
Napoli 56
Amsterdam 54
New York 44
Tokyo 42
Lawrence 41
Helsinki 35
Des Moines 33
Haiphong 31
Buffalo 30
Kochi 30
Dallas 29
Milan 29
Redondo Beach 29
Boston 28
Frankfurt am Main 28
Da Nang 25
São Paulo 25
Seoul 24
Wilmington 23
Council Bluffs 18
Rome 18
Warsaw 17
Falkenstein 16
Johannesburg 16
Orem 16
London 15
Montreal 15
Princeton 15
Seattle 15
Turku 15
Valencia 15
Biên Hòa 14
Chicago 14
Heraklion 14
Nanjing 14
Chennai 13
Denver 13
Mexico City 13
Nuremberg 13
Stockholm 13
Atlanta 12
Brooklyn 12
Can Tho 11
Rio de Janeiro 11
Bologna 10
Dublin 10
Fairfield 10
Houston 10
San Francisco 10
Toronto 10
Hải Dương 9
Manchester 9
Tashkent 9
Amman 8
Ankara 8
Messina 8
Poplar 8
Salerno 8
Salt Lake City 8
Baghdad 7
Bari 7
Lappeenranta 7
Long Xuyen 7
Marcianise 7
Nanchang 7
New Delhi 7
Ottawa 7
Phoenix 7
Bangkok 6
Grosseto 6
Ninh Bình 6
Quận Ba 6
Washington 6
Woodbridge 6
Belo Horizonte 5
Bắc Giang 5
Casalnuovo di Napoli 5
Caserta 5
Changsha 5
Guarulhos 5
Jinan 5
Krefeld 5
Lahore 5
Totale 4.739
Nome #
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 213
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 176
Analysis of human primary fibroblast spheroids 173
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 171
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 164
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 163
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 160
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 159
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 156
Beta-Catenin Regulates Deiodinase Levels and Thyroid Hormone Signaling in Colon Cancer Cells 155
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 154
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 153
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 152
UbcH10 expression in human lymphomas. 152
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 149
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 148
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 148
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 147
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 147
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 145
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 141
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 138
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 137
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 136
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 136
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 133
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 133
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 132
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 128
Predictive molecular pathology in the time of COVID-19 128
Methods for actionable gene fusion detection in lung cancer: now and in the future 128
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 126
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 123
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 122
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 119
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 119
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 119
Tumor mutational burden on cytological samples: A pilot study 118
Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine-needle aspirates suspicious for Hurthle cell neoplasms. 117
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 117
BRAF: A Two-Faced Janus 117
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 116
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 116
PD-L1 and beyond: Immuno-oncology in cytopathology 116
NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through FAS/CD95 Inhibition 114
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 114
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 113
PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. 111
EGFR analysis: Current evidence and future directions 110
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 110
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 106
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 105
Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy 104
UbcH10 expression on thyroid fine-needle aspirates. 102
Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein 100
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 100
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 100
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 96
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 96
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors 90
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 90
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 89
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 88
Warthin tumor with signet-ring cell features as a pitfall in salivary gland cytopathology. 86
Juggling the COVID-19 pandemic: A cytopathology point of view 86
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 83
p27(Kip1) expression and grading of breast cancer diagnosed on cytological samples. 81
Liquid Biopsy in Solid Tumours: An Overview 78
Cytology in the time of coronavirus disease (covid-19): An Italian perspective 76
Evaluation of a New Ethanol-Based Preservative Medium for Liquid-Based Cervical Cytology: A Performance Pilot Study for Molecular Applications 75
Reference standards for gene fusion molecular assays on cytological samples: an international validation study 69
Molecular predictive testing in precision oncology: The Italian experience 60
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe 49
Pathology in non-small cell lung cancer: evolving scenario 49
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution 39
Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma 15
Totale 8.984
Categoria #
all - tutte 27.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022396 10 10 8 14 6 1 9 34 31 46 102 125
2022/2023604 61 27 28 35 87 75 2 54 103 57 62 13
2023/2024440 32 62 47 25 16 33 9 80 17 15 56 48
2024/20252.476 111 124 7 26 61 127 246 181 135 300 965 193
2025/20264.662 456 333 521 398 824 215 622 255 523 353 152 10
Totale 8.984